A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants

NCT06007638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3876602
DRUG: Placebo

Sponsor

Eli Lilly and Company